Technology bolsters the pharma industry; creates M&A opportunities

Technology is playing an increasingly important role in the life sciences and pharmaceutical industry, leading to an increase in M&A opportunities for strategic and private equity investors. 

CIL’s Rebecca Pigula recently joined the Association of Corporate Growth to discuss the increasing use of technology within pharma services and life sciences. Watch the video below to hear what the panelists think about:

• The pace of technological change in the industry, and what this means for investor opportunities
• How the use of technology in pharma is changing how patients participate in clinical trials
• The outlook for the industry, including areas of particular interest to investors